Motion - Genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: Arguments against the motion

Canadian Journal of Gastroenterology

Volumn 17, Issue 1, 2003, Pages 53-55

  Cohn, Jonathan A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; DNA mutational analysis; Genetic predisposition to disease; Kazal pancreatic; Pancreatitis; Polymorphism (genetics); Trypsin inhibitor

Indexed keywords

APROTININ; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ARTICLE; CHRONIC HEPATITIS; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC RISK; HETEROZYGOTE; HUMAN; PANCREAS DISEASE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING;

EID: 0037224076     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/169280     Document Type: Article

References (17)

1. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52.
2. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653-8.
3. Arduino C, Gallo M, Brusco A, et al. Polyvariant mutant CFTR genes in patients with chronic pancreatitis. Clin Genet 1999;56:400-4.
4. Naruse S, Kitagawa M, Ishiguro H. Molecular understanding of chronic pancreatitis: A perspective on the future. Mol Med Today 1999;5:493-9.
5. Choudari CP, Lehman GA, Sherman S. Pancreatitis and cystic fibrosis gene mutations. Gastroenterol Clin N Am 1999;28:543-9.
6. Castellani C, Bonizzato A, Rolfini R, Frulloni L, Cavallini GC, Mastella G. Increased prevalence of mutations of the cystic fibrosis gene in idiopathic chronic and recurrent pancreatitis. Am J Gastroenterol 1999;94:1993-5.
7. Liddle RA, Cohn JA. Hereditary diseases of the pancreas. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of Gastroenterology, 3rd edn. New York: JB Lippincott, 1999:2229-43.
8. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;35:213-6.
9. Cohn JA, Bornstein JD, Jowell PS. Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis. Med Clin North Am 2000;84:621-31.
10. Ockenga J, Stuhrmann M, Ballmann M, et al. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 2000;95:2061-7.
11. Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682-707.
12. Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: Relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001;121:1310-9.
13. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: A consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-95.
14. Pfutzer RH, Barmada MM, Brunskill AP, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
15. Ockenga J, Dork T, Stuhrmann M. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis. J Med Genet 2001;38:243-4.
16. Cohn JA, Melhus O, Page LJ, Dittrich KL, Vigna SR. CFTR: Development of high-affinity antibodies and localization in sweat gland. Biochem Biophys Res Commun 1991;181:36-43.
17. Marino CR, Matovcik LM, Gorelick FS, Cohn JA. Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. J Clin Invest 1991;88:712-6.